Ascendis Pharma A/S

SecurityASND / Ascendis Pharma A/S
InstitutionGroup One Trading, L.p.
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Group One Trading, L.p. ownership in ASND / Ascendis Pharma A/S

On November 12, 2025 - Group One Trading, L.p. filed a 13F-HR form disclosing ownership of 0 shares of Ascendis Pharma A/S (US:ASND) valued at $0 USD as of September 30, 2025. The entity filed a previous 13F-HR on August 14, 2025 disclosing 142 shares of Ascendis Pharma A/S. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Group One Trading, L.p. has a history of taking positions in derivatives of the underlying security (ASND) in the form of stock options. The firm currently holds call options representing 18,400 of underlying shares valued at $3,923,616 USD and put options representing 1,500 of underlying shares valued at $319,860 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

ASND / Ascendis Pharma A/S Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-11-12 2025-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 0 -142 -100.00 0 -100.00
2025-08-14 2025-06-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 142 -3,636 -96.24 25 -95.92 0.0001
2025-05-14 2025-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 3,778 -323 -7.88 589 4.26 0.0017
2025-05-14 2024-12-31 13F/A-1 ASCENDIS PHARMA A SPONSORED ADR 04351P101 4,101 4,101 565 0.0013
2025-02-14 2024-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 4,101 4,101 565 0.0014
2024-05-10 2024-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 0 -5,808 -100.00 0 -100.00
2024-02-14 2023-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 5,808 2,964 104.22 732 174.81 0.0019
2023-11-09 2023-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 2,844 2,844 266 0.0009
2023-05-12 2023-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 0 -1,235 -100.00 0 -100.00
2023-02-09 2022-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 1,235 -16,130 -92.89 151 -91.63 0.0004
2022-11-09 2022-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 17,365 11,321 187.31 1,793 219.04 0.0035
2022-08-11 2022-06-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 6,044 6,044 562 0.0009
2021-11-12 2021-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 0 -11 -100.00 0 -100.00
2021-08-10 2021-06-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 11 -220 -95.24 1 -96.67 0.0000
2021-05-12 2021-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 231 -710 -75.45 30 -80.89 0.0000
2021-02-10 2020-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 941 941 157 0.0003
2020-08-13 2020-06-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 0 -569 -100.00 0 -100.00
2020-05-13 2020-03-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 569 -1,219 -68.18 64 -74.30 0.0005
2020-02-10 2019-12-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 1,788 565 46.20 249 111.02 0.0017
2019-11-12 2019-09-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 1,223 -4,392 -78.22 118 -81.76 0.0010
2019-08-09 2019-06-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 5,615 5,615 647 0.0059
2019-05-14 2019-03-31 13F/A-1 ASCENDIS PHARMA A S SPONSORED ADR 04351P101 0 -1,345 -100.00 0 -100.00
2019-02-05 2018-12-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 1,345 1,345 84 0.0007
2018-11-08 2018-09-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 0 -98 -100.00 0 -100.00
2018-08-13 2018-06-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 98 98 7 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F ASCENDIS PHARMA A SPONSORED ADR Call 18,400 -14.81 3,924 -8.64 n/a n/a n/a
2025-11-12 2025-09-30 13F ASCENDIS PHARMA A SPONSORED ADR Call 21,600 1,442.86 4,294 1,681.74 n/a n/a n/a
2025-08-14 2025-06-30 13F ASCENDIS PHARMA A SPONSORED ADR Call 1,400 600.00 242 677.42 n/a n/a n/a
2025-05-14 2025-03-31 13F ASCENDIS PHARMA A SPONSORED ADR Call 200 -96.23 31 -95.75 n/a n/a n/a
2025-05-14 2024-12-31 13F/A ASCENDIS PHARMA A SPONSORED ADR Call 5,300 -53.51 730 -57.17 n/a n/a n/a
2025-02-14 2024-12-31 13F ASCENDIS PHARMA A SPONSORED ADR Call 5,300 730 n/a n/a n/a
2024-11-14 2024-09-30 13F ASCENDIS PHARMA A SPONSORED ADR Call 11,400 776.92 1,702 861.58 n/a n/a n/a
2024-08-14 2024-06-30 13F ASCENDIS PHARMA A SPONSORED ADR Call 1,300 -7.14 177 -16.11 n/a n/a n/a
2024-05-10 2024-03-31 13F ASCENDIS PHARMA A SPONSORED ADR Call 1,400 250.00 212 322.00 n/a n/a n/a
2024-02-14 2023-12-31 13F ASCENDIS PHARMA A SPONSORED ADR Call 400 -50.00 50 -32.43 n/a n/a n/a
2023-11-09 2023-09-30 13F ASCENDIS PHARMA A SPONSORED ADR Call 800 -94.97 75 -94.79 n/a n/a n/a
2023-08-09 2023-06-30 13F ASCENDIS PHARMA A SPONSORED ADR Call 15,900 -70.99 1,419 -75.85 n/a n/a n/a
2023-05-12 2023-03-31 13F ASCENDIS PHARMA A SPONSORED ADR Call 54,800 123.67 5,876 96.36 n/a n/a n/a
2023-02-09 2022-12-31 13F ASCENDIS PHARMA A SPONSORED ADR Call 24,500 -41.94 2,992 -31.34 n/a n/a n/a
2022-11-09 2022-09-30 13F ASCENDIS PHARMA A SPONSORED ADR Call 42,200 4,358 n/a n/a n/a
2022-08-11 2022-06-30 13F ASCENDIS PHARMA A SPONSORED ADR Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-12 2022-03-31 13F ASCENDIS PHARMA A SPONSORED ADR Call 1,900 223 n/a n/a n/a
2022-02-11 2021-12-31 13F ASCENDIS PHARMA A SPONSORED ADR Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-12 2021-09-30 13F ASCENDIS PHARMA A SPONSORED ADR Call 500 150.00 80 207.69 n/a n/a n/a
2021-08-10 2021-06-30 13F ASCENDIS PHARMA A SPONSORED ADR Call 200 -50.00 26 -50.00 n/a n/a n/a
2021-05-12 2021-03-31 13F ASCENDIS PHARMA A SPONSORED ADR Call 400 52 n/a n/a n/a
2021-02-10 2020-12-31 13F ASCENDIS PHARMA A SPONSORED ADR Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-11-12 2020-09-30 13F ASCENDIS PHARMA A SPONSORED ADR Call 5,100 -29.17 787 -26.10 n/a n/a n/a
2020-08-13 2020-06-30 13F ASCENDIS PHARMA A S SPONSORED ADR Call 7,200 3,500.00 1,065 4,530.43 n/a n/a n/a
2020-05-13 2020-03-31 13F ASCENDIS PHARMA A S SPONSORED ADR Call 200 -81.82 23 -84.97 n/a n/a n/a
2020-02-10 2019-12-31 13F ASCENDIS PHARMA A S SPONSORED ADR Call 1,100 10.00 153 59.38 n/a n/a n/a
2019-11-12 2019-09-30 13F ASCENDIS PHARMA A S SPONSORED ADR Call 1,000 -91.07 96 -92.56 n/a n/a n/a
2019-08-09 2019-06-30 13F ASCENDIS PHARMA A S SPONSORED ADR Call 11,200 -82.55 1,290 -82.93 n/a n/a n/a
2019-05-14 2019-03-31 13F/A ASCENDIS PHARMA A S SPONSORED ADR Call 64,200 32,000.00 7,556 58,023.08 n/a n/a n/a
2019-05-13 2019-03-31 13F ASCENDIS PHARMA A S SPONSORED ADR Call 64,200 7,556 n/a n/a n/a
2019-02-05 2018-12-31 13F ASCENDIS PHARMA A S SPONSORED ADR Call 200 -89.47 13 -90.37 n/a n/a n/a
2018-11-08 2018-09-30 13F ASCENDIS PHARMA A S SPONSORED ADR Call 1,900 135 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F ASCENDIS PHARMA A SPONSORED ADR Put 1,500 -76.56 320 -74.92 n/a n/a n/a
2025-11-12 2025-09-30 13F ASCENDIS PHARMA A SPONSORED ADR Put 6,400 178.26 1,272 221.21 n/a n/a n/a
2025-08-14 2025-06-30 13F ASCENDIS PHARMA A SPONSORED ADR Put 2,300 -79.46 397 -77.31 n/a n/a n/a
2025-05-14 2025-03-31 13F ASCENDIS PHARMA A SPONSORED ADR Put 11,200 13.13 1,746 28.12 n/a n/a n/a
2025-05-14 2024-12-31 13F/A ASCENDIS PHARMA A SPONSORED ADR Put 9,900 47.76 1,363 36.20 n/a n/a n/a
2025-02-14 2024-12-31 13F ASCENDIS PHARMA A SPONSORED ADR Put 9,900 1,363 n/a n/a n/a
2024-11-14 2024-09-30 13F ASCENDIS PHARMA A SPONSORED ADR Put 6,700 -62.78 1,000 -59.25 n/a n/a n/a
2024-08-14 2024-06-30 13F ASCENDIS PHARMA A SPONSORED ADR Put 18,000 2,455 n/a n/a n/a
2024-05-10 2024-03-31 13F ASCENDIS PHARMA A SPONSORED ADR Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-02-14 2023-12-31 13F ASCENDIS PHARMA A SPONSORED ADR Put 4,600 -62.60 579 -49.70 n/a n/a n/a
2023-11-09 2023-09-30 13F ASCENDIS PHARMA A SPONSORED ADR Put 12,300 1.65 1,152 6.67 n/a n/a n/a
2023-08-09 2023-06-30 13F ASCENDIS PHARMA A SPONSORED ADR Put 12,100 1,080 n/a n/a n/a
2023-05-12 2023-03-31 13F ASCENDIS PHARMA A SPONSORED ADR Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-09 2022-12-31 13F ASCENDIS PHARMA A SPONSORED ADR Put 2,800 -62.67 342 -55.94 n/a n/a n/a
2022-11-09 2022-09-30 13F ASCENDIS PHARMA A SPONSORED ADR Put 7,500 0.00 774 11.05 n/a n/a n/a
2022-08-11 2022-06-30 13F ASCENDIS PHARMA A SPONSORED ADR Put 7,500 1,775.00 697 1,382.98 n/a n/a n/a
2022-05-12 2022-03-31 13F ASCENDIS PHARMA A SPONSORED ADR Put 400 100.00 47 74.07 n/a n/a n/a
2022-02-11 2021-12-31 13F ASCENDIS PHARMA A SPONSORED ADR Put 200 0.00 27 -15.62 n/a n/a n/a
2021-11-12 2021-09-30 13F ASCENDIS PHARMA A SPONSORED ADR Put 200 -77.78 32 -72.88 n/a n/a n/a
2021-08-10 2021-06-30 13F ASCENDIS PHARMA A SPONSORED ADR Put 900 125.00 118 126.92 n/a n/a n/a
2021-05-12 2021-03-31 13F ASCENDIS PHARMA A SPONSORED ADR Put 400 100.00 52 57.58 n/a n/a n/a
2021-02-10 2020-12-31 13F ASCENDIS PHARMA A SPONSORED ADR Put 200 -96.15 33 -95.89 n/a n/a n/a
2020-11-12 2020-09-30 13F ASCENDIS PHARMA A SPONSORED ADR Put 5,200 1.96 802 6.37 n/a n/a n/a
2020-08-13 2020-06-30 13F ASCENDIS PHARMA A S SPONSORED ADR Put 5,100 5,000.00 754 6,754.55 n/a n/a n/a
2020-05-13 2020-03-31 13F ASCENDIS PHARMA A S SPONSORED ADR Put 100 -50.00 11 -60.71 n/a n/a n/a
2020-02-10 2019-12-31 13F ASCENDIS PHARMA A S SPONSORED ADR Put 200 -80.00 28 -70.83 n/a n/a n/a
2019-11-12 2019-09-30 13F ASCENDIS PHARMA A S SPONSORED ADR Put 1,000 -97.21 96 -97.68 n/a n/a n/a
2019-08-09 2019-06-30 13F ASCENDIS PHARMA A S SPONSORED ADR Put 35,900 37.55 4,134 34.57 n/a n/a n/a
2019-05-14 2019-03-31 13F/A ASCENDIS PHARMA A S SPONSORED ADR Put 26,100 667.65 3,072 1,342.25 n/a n/a n/a
2019-05-13 2019-03-31 13F ASCENDIS PHARMA A S SPONSORED ADR Put 26,100 3,072 n/a n/a n/a
2019-02-05 2018-12-31 13F ASCENDIS PHARMA A S SPONSORED ADR Put 3,400 3,300.00 213 2,942.86 n/a n/a n/a
2018-11-08 2018-09-30 13F ASCENDIS PHARMA A S SPONSORED ADR Put 100 0.00 7 0.00 n/a n/a n/a
2018-08-13 2018-06-30 13F ASCENDIS PHARMA A S SPONSORED ADR Put 100 7 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.